Key result
Morphine for AMI chest pain lacks rigorous evidence and risks delaying antiplatelet action.
Why the study?
Clinical practice guidelines strongly recommend morphine for analgesia in AMI patients despite the absence of rigorous studies assessing its impact and potential side effects.
Does morphine administration safely relieve chest pain in patients with acute myocardial infarction?
Does morphine administration safely relieve chest pain in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Morphine administration for chest pain in AMI, though recommended by guidelines, is associated with significant side effects including delayed onset of antiplatelet agents.
Chest pain is the prevalent symptom at presentation in patients with acute myocardial infarction (AMI). Despite the complete absence of rigorous studies designed to assess the impact of morphine administration in patients with AMI, clinical practice guidelines strongly recommend morphine for analgesia. However, when using morphine to relieve chest pain in AMI patients, physicians must be aware that hypotension, respiratory depression, vomiting, and delayed onset of action of antiplatelet agents are potential unwanted side effects of the drug. The purpose of this report is to review morphine's clinical and side effects and to propose strategies able to reduce chest pain in AMI patients.
No takes yet. Share an insight, caveat, or question.
Guido Parodi (2015) conducted a review in Acute myocardial infarction (AMI). Morphine was evaluated. Morphine administration for chest pain in acute myocardial infarction lacks rigorous study and carries risks of hypotension, respiratory depression, vomiting, and delayed antiplatelet action.
Synapse has enriched 10 related papers. Consider them for comparative context: